S. 4332 Introduced Health

Medication Competition Act

A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.

  1. Introduced
  2. Committee
  3. Passed Senate
  4. Passed House
  5. To President
  6. Became law
Sponsor Sen. Hassan, Margaret Wood [D-NH] Introduced April 16, 2026 Cosponsors 1 (1 R) Latest action April 16, 2026

Summary

The Congressional Research Service has not published a summary of this bill yet.

Congress.gov

Actions

  1. Apr 16, 2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Apr 16, 2026 Introduced in Senate

Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Search index and reflect what the press published, not 4Search's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.